Septerna (SEPN) Share-based Compensation (2023 - 2026)
Septerna (SEPN) recorded quarterly Share-based Compensation of $6.0 million in Q1 2026, up 126.47% quarter-over-quarter from $2.7 million in Q4 2025, and up 305.87% on a YoY basis from $1.5 million in Q1 2025.
Septerna (SEPN) Share-based Compensation (2023 - 2026) Analysis & Trends
Septerna's Share-based Compensation history runs 4 years deep, the most recent figure standing at $6.0 million for Q1 2026.
- In Q1 2026, Share-based Compensation rose 305.87% year-over-year to $6.0 million; the TTM figure through Mar 2026 stood at $13.0 million (up 220.66% YoY), while the FY2025 annual figure was $8.5 million, up 168.91% from the prior year.
- Share-based Compensation was $6.0 million for Q1 2026 at Septerna, up from $2.7 million in the prior quarter.
- In the past five years, Share-based Compensation ranged from a high of $6.0 million in Q1 2026 to a low of $347000.0 in Q3 2023.
- Historically, Share-based Compensation has averaged $1.7 million across 4 years, with a median of $1.3 million in 2024.
- The sharpest annual moves came in 2024 and 2026: Share-based Compensation surged 96.83% in 2024, then jumped 305.87% in 2026.
- A 4-year view of Share-based Compensation shows it stood at $575000.0 in 2023, then soared by 119.83% to $1.3 million in 2024, then surged by 110.13% to $2.7 million in 2025, then surged by 126.47% to $6.0 million in 2026.
- The last three Share-based Compensation figures came in at $6.0 million (Q1 2026), $2.7 million (Q4 2025), and $2.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 305,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 166.40 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 26.47 Mn |
| 10 | Septerna | 1.62 Bn | 1.62 Bn | - | 6.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.02 Mn |
| Mar 31, 2026 | 6.02 Mn |
| Dec 31, 2025 | 2.66 Mn |
| Dec 31, 2025 | 2.66 Mn |
| Sep 30, 2025 | 2.53 Mn |
| Sep 30, 2025 | 2.53 Mn |
| Jun 30, 2025 | 1.81 Mn |
| Jun 30, 2025 | 1.81 Mn |
| Mar 31, 2025 | 1.48 Mn |
| Mar 31, 2025 | 1.48 Mn |
| Dec 31, 2024 | 1.26 Mn |
| Dec 31, 2024 | 1.26 Mn |
| Sep 30, 2024 | 683,000.00 |
| Sep 30, 2024 | 683,000.00 |
| Jun 30, 2024 | 628,000.00 |
| Jun 30, 2024 | 628,000.00 |
| Mar 31, 2024 | 577,000.00 |
| Mar 31, 2024 | 577,000.00 |
| Dec 31, 2023 | 575,000.00 |
| Dec 31, 2023 | 575,000.00 |